McLeod J et al. |
Effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on substance P-induced histamine release from rat peritoneal mast cells. |
1990 |
Agents Actions |
pmid:1695435
|
Bekemeier H and Sänze JU |
Vasodepression ex vivo after administration of inflammatory mediators in vivo in the rat. |
1989 |
Agents Actions |
pmid:2476918
|
Jouquey S et al. |
Comparison of the effects of the ace inhibitors trandolapril and enalapril on phlogogen induced foot pad oedema in the rat. |
1988 |
Agents Actions |
pmid:2459935
|
Sanchez Crespo M and Nieto ML |
Modulation of PAF biosynthesis in human polymorphonuclear leukocytes. The role of phorbol esters and protein kinases. |
1989 |
Agents Actions |
pmid:2711927
|
Zijlstra FJ et al. |
The effects of PAF-acether and FMLP on eicosanoid production in guinea pig alveolar macrophages. |
1989 |
Agents Actions |
pmid:2711928
|
Nijkamp FP et al. |
Role of platelet activating factor in the endotoxin induced tracheal hyperreactivity to histamine in the guinea pig. |
1989 |
Agents Actions |
pmid:2711929
|
Oliver JL et al. |
Effect of PAF acether on oriented egg phosphatidylcholine multibilayers; interaction with cholesterol; comparison to lyso-PC and lyso-PAF. |
1989 |
Agents Actions |
pmid:2711930
|
Jenei B et al. |
Hypotensive action of IgG preparations containing aggregates is suppressed by PAF-receptor antagonist BN 52021 and by gadolinium chloride (an agent blocking Kupffer cell function). |
1991 |
Agents Actions |
pmid:1862750
|
Kantar A et al. |
Effect of PAF on erythrocyte membrane heterogeneity: a fluorescence study. |
1991 |
Agents Actions |
pmid:1862752
|
Carlson RP et al. |
Pharmacologic modulation of PAF-induced mortality in mice. |
1987 |
Agents Actions |
pmid:3120513
|
Anderson GP et al. |
Increased airways responsiveness to histamine induced by platelet activating factor in the guinea-pig: possible role of lipoxygenase metabolites. |
1988 |
Agents Actions |
pmid:3136622
|
Kusner EJ et al. |
Pharmacologic analysis of 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine-induced increases in cutaneous vascular permeability in the rat. |
1987 |
Agents Actions |
pmid:3577957
|
Glaser KB et al. |
Pharmacological characterization of WAY-121,520: a potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2). |
1993 |
Agents Actions |
pmid:8273577
|
Lefort J et al. |
Pharmacological properties of PAF-acether in the guinea-pig: platelet-dependent and independent reactions. |
1982 |
Agents Actions |
pmid:7164948
|
Denjean A et al. |
Bronchoconstriction induced by intratracheal administration of platelet-activating factor (PAF-acether) in baboons. |
1981 |
Agents Actions |
pmid:7340444
|
Izzo AA et al. |
Platelet activating factor potentiates rat paw oedema induced by different phlogogen agents. |
1994 |
Agents Actions |
pmid:7524288
|
Lartigue-Mattei C et al. |
Pharmacokinetic study of 3H-labelled PAF-acether II. Comparison with 3H-labelled lyso-PAF-acether after intravenous administration in the rabbit and protein binding. |
1984 |
Agents Actions |
pmid:6532184
|
Kurosawa M |
Effect of platelet activating factor on histamine release from rat mast cells. |
1987 |
Agents Actions Suppl. |
pmid:2445185
|
Szczeklik A et al. |
Bleeding time and PAF-acether-induced platelet aggregation in atopy. |
1987 |
Agents Actions Suppl. |
pmid:3478996
|
Page CP and Robertson DN |
Properties of PAF relevant to asthma. |
1987 |
Agents Actions Suppl. |
pmid:3314416
|